查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1892124

家庭医疗保健领域的创新与成长机会

Healthcare at Home Innovation and Growth Opportunities
出版日期: | 出版商: Frost & Sullivan | 英文 57 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

在家即可享受个人化、便利的医院级疾病管理服务

受门诊服务以及居家监测、治疗和復健需求成长的推动，居家医疗已成为现代医学领域发展最快的领域之一。诊所和医院患者数量的不断增加促使联邦政府推出主导，以促进采用创新解决方案，实现分散式医疗服务。新冠疫情加速了这一趋势，监管机构已授予市售远端监测设备和数位疗法紧急使用授权，使这些技术能够在主流医疗保健中发挥合法作用。

居家医疗技术涵盖技术创新、易用性和成本效益，使其成为研究人员和行业相关人员关注的重点分析领域。本研究探讨了正在重塑传统医疗保健服务模式的新兴全球趋势，重点是数位疗法、穿戴式装置和智慧型手机监测平台。研究尤其关注心血管疾病和精神疾病管理领域的应用，这些领域在居家医疗环境中正迅速普及。本研究不仅评估了这些创新的优势和技术成熟度，也确定了未来五年可能塑造竞争格​​局的关键企业和技术开发人员。

目录

家庭医疗保健领域的创新与成长机会

  • 策略要务
  • 为什么成长变得越来越困难
  • The Strategic Imperative 8
  • 三大策略要务对居家医疗产业的影响
  • 成长引擎由成长机会驱动
  • 调查方法

成长机会分析

  • 分析范围
  • 居家医疗PPP 价值三要素－病人真的能在医院復健吗？
  • 居家医疗的具体影响和益处
  • 居家医疗服务模式
  • 推动居家医疗产业转型发展的关键演进趋势
  • 美国食品药物管理局(FDA)居家医疗指南的主要要点
  • FDA已通过核准的家用医疗设备（510k）
  • 分割

成长泉

  • 成长要素
  • 成长抑制因素

技术概述

  • 去心房颤动- 概述
  • 2020年至2025年间拥有临床核准的AED和WCD的公司
  • 血压计概述
  • 需要采取行动的公司－2020年至2025年间获得临床核准的血压监测仪

技术概述

  • 精神健康数位化治疗作为医疗设备软体（SaMD）—概述
  • 激励行动的公司－2020年至2025年临床核准的精神健康直接治疗药物
  • 未来技术蓝图

相关人员生态系统

  • 临床试验资料库分析
  • 居家医疗创新专利申请分析（2021-2025）
  • 美国联邦资金分析
  • 私人资金筹措分析
  • 併购趋势（2023-2024）

成长机会领域

  • 成长机会一：聚焦两个尚未开发的市场：印度市场与药物滥用问题
  • 成长机会 2：家庭医疗设备技术开发商与护理即服务 (CaaS) 提供者之间的合作
  • 成长机会3：优先考虑女性作为最终使用者和护理协调员的技术开发人员

附录

  • 技术成熟度等级（TRL）解释

未来计划

  • 成长机会带来的益处和影响
  • 下一步
  • 免责声明
简介目录
Product Code: DB4A

Personalized and Accessible Hospital-Grade Disease Management at Home

Healthcare at home is emerging as one of the fastest-growing fields in modern medicine, driven by the rising demand for outpatient services, home-based monitoring, treatment, and rehabilitation. Increasing patient loads in clinics and hospitals have spurred federal initiatives that encourage the adoption of innovative solutions for decentralized care delivery. The pandemic accelerated this momentum, during which regulatory authorities granted emergency use authorization for over-the-counter remote monitoring devices and digital therapeutics, legitimizing their role in mainstream healthcare.

The scope of healthcare at home technologies spans technical innovation, user-friendliness, and cost-effectiveness, making them a critical area of analysis for researchers and industry stakeholders. This study explores emerging global trends reshaping conventional healthcare delivery models, focusing on digital therapeutics, wearable devices, and smartphone-enabled monitoring platforms. Special attention is given to their applications in managing cardiovascular diseases and mental health conditions, which are witnessing rapid uptake in home-care settings. In addition to assessing these innovations' advantages and technology readiness levels, the study identifies leading incumbents and technology developers poised to shape the competitive landscape over the next 5 years.

Table of Contents

Healthcare at Home Innovations & Growth Opportunities

  • Strategic Imperatives
  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the Healthcare at Home Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • PPP Value Triad of Healthcare at Home-Do Patients Really Heal in Hospitals?
  • Elaborate Implications and Benefits of Healthcare at Home
  • Healthcare at Home Care Delivery Model
  • Key Evolving Trends Leading to Industry Shifts in Healthcare at Home
  • Key Takeaways from the US Food & Drug Administration FDA Guidelines for Healthcare at Home
  • 510k FDA-Approved Home-Use Medical Devices
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Technology Snapshot

  • Defibrillators-Overview
  • Companies to Action-AEDs and WCDs Clinically Cleared between 2020 and 2025
  • BP Monitors-Overview
  • Companies to Action-Clinically Cleared BP Monitors between 2020 and 2025

Technology Snapshot

  • Mental Health DTx as Software as a Medical Device SaMD-Overview
  • Companies to Action-Clinically Approved Mental Health DTx between 2020 and 2025
  • Future Technology Roadmap

Stakeholder Ecosystem

  • Clinical Trials Database Analytics
  • Filed Patent Analysis for Healthcare at Home Innovations, 2021-2025
  • Federal Funding Analysis in the United States
  • Private Funding Analysis
  • Mergers and Acquisitions, 2023-2024

Growth Opportunity Universe

  • Growth Opportunity 1: Targeting 2 Untapped Markets: India and Substance Overuse
  • Growth Opportunity 2: Partnerships between Technology Developers of Home-Use Medical Devices and Care-as-a-Service CaaS Providers
  • Growth Opportunity 3: Technology Developers Prioritizing Women as End Users and Care Coordinators

Appendix

  • Technology Readiness Levels TRL: Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer